NLS Pharmaceutics Stock Analysis - Day Typical Price

Delisted . USA . 
Delisted Stock . NLS Pharmaceutics AG
NLSPDelisted Delisted Stock  USD 7.62  -0.08  -1.04%   
Typical Price is the average of the high, low, and close, providing a balanced view of intraday price action.

Day Typical Price Analysis Today

Typical Price is the average of the high, low, and close, providing a balanced view of intraday price action. The current Day Typical Price for NLS Pharmaceutics AG is 7.84. This reading indicates consistent price behavior relative to the prior session.
  Previous Day Typical PriceDay Typical PriceTrend
7.847.84
VolatilityBacktestInformation Ratio  

NLS Pharmaceutics Trading Date Momentum

On May 08 2026 NLS Pharmaceutics AG was traded for 7.62 at the closing time. The top price for the day was 8.30 and the lowest listed price was 7.60 . Trading activity remained within a narrow range during the period. Price movement on May 8, 2026 remained within defined bounds. The trading delta at closing time against the current closing price is 1.05% .
By including the close alongside the high-low range, Typical Price gives more weight to the settlement level than Median Price does. It is frequently used as an input for volume-weighted indicators and pivot point calculations.
Compare NLS Pharmaceutics to competition

NLS Pharmaceutics Comparable Listed Equities

These listed companies frame NLS Pharmaceutics's former industry context and operating niche. For a delisted instrument, comparable peers are more useful for sector reference than for direct trading signals or return forecasting.

NLS Pharmaceutics Market Strength Events

Market strength indicators for NLS Pharmaceutics stock provide a framework for assessing security responsiveness. A rising Accumulation/Distribution line alongside rising price confirms institutional buying interest in NLS Pharmaceutics.
Accumulation Distribution0.0843
Daily Balance Of Power-0.11
Rate Of Daily Change0.99
Day Median Price7.95
Day Typical Price7.84
Market Facilitation Index0.7
Price Action Indicator-0.37
Period Momentum Indicator-0.08
Relative Strength Index29.86

NLS Pharmaceutics Risk Indicators

Assessing NLS Pharmaceutics' risk indicators is a structured way to evaluate the risk-return trade-off for nls stock. The level of risk embedded in NLS Pharmaceutics' feeds directly into exposure calibration.
Mean Deviation5.08
Standard Deviation7.43
Variance55.19
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

NLS Pharmaceutics Short Properties

Reviewing short-oriented indicators for NLS Pharmaceutics is useful because long and short participants often create very different signals for timing and volatility. This is applicable when the question is whether bearish pressure is starting to shape the market's reaction function.
Common Stock Shares Outstanding1.54 million
Cash And Short Term Investments1.67 million
NLS Pharmaceutics has a market cap of 3.97 million, current ratio of 0.59. These figures offer a starting point for comparing against sector peers. Broader economic conditions can influence NLS Pharmaceutics AG's company valuation - related indicators include signals in population.
NLS Pharmaceutics currently shows ROE of -8.63%, market cap of USD 3.97 million. Analysis of NLS Pharmaceutics gains depth when combined with the construction and diversification tools listed below. For NLS Pharmaceutics, the analytical tools below add portfolio-level context that single-security review alone does not provide. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Related Tools for NLS Stock

OTC execution conditions for NLS Pharmaceutics may differ materially from major exchanges.
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.